Home lactulose enema: prevention of hepatic encephalopathy at home

被引：3
|
作者：
Saito, T [1 ]
Shinzawa, H [1 ]
Watanabe, H [1 ]
Togashi, H [1 ]
Kawata, S [1 ]
机构：
[1] Yamagata Univ, Sch Med, Dept Internal Med 2, Yamagata 9909585, Japan
来源：
JOURNAL OF GASTROENTEROLOGY | 2002年 / 37卷 / 01期
关键词：
Hepatic Encephalopathy; Lactulose;
D O I：
10.1007/s535-002-8136-7
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：68 / 69
页数：2
相关论文
共 50 条
  • [21] Barriers to Lactulose Adherence in Patients with Cirrhosis and Hepatic Encephalopathy
    Chow, Kenneth W.
    Ibrahim, Brittney M.
    Yum, Jung J.
    Dang, An
    Dang, Long
    Chen, Kuan-Ting
    Jackson, Nicholas J.
    Saab, Sammy
    DIGESTIVE DISEASES AND SCIENCES, 2023, 68 (06) : 2389 - 2397
  • [22] Prevention of hepatic encephalopathy
    Morillas, Rosa M.
    Sala, Marga
    Planas, Ramon
    MEDICINA CLINICA, 2014, 142 (11): : 512 - 514
  • [23] RCT RESEATCH STUDY FOR CURING HEPATIC ENCEPHALOPATHY AND ITS COMPARISON WITH LACTULOSE ONLY TREATMENT, THE EVALUATION OF USEFULNESS, FOR TREATMENT OF HEPATIC ENCEPHALOPATHY
    Sattar, Shaneela
    Bibi, Kashifa
    Muhammad
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 5 (10): : 9927 - 9932
  • [24] Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis
    Gluud, Lise Lotte
    Vilstrup, Hendrik
    Morgan, Marsha Y.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (04):
  • [25] EFFICACY OF LACTULOSE VS LACTULOSE WITH RIFAXAMIN IN PATIENTS WITH HEPATIC ENCEPHALOPATHY; A RANDOMIZED CONTROL TRIAL
    Ahmed, Bilal
    Javaid, Suman
    Batool, Narjis
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 6 (06): : 12241 - 12244
  • [26] Efficacy of lactulose in the prophylaxis of hepatic encephalopathy in cirrhotic patients presenting gastrointestinal bleeding
    Aires, Felipe Toyama
    Ramos, Paola Teruya
    Bernardo, Wanderley Marques
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2016, 62 (03): : 243 - 247
  • [27] EFFECT OF USING LACTULOSE AND RIFAXIMIN IN COMPARISON WITH LACTULOSE ONLY THERAPY IN TREATEMENT OF HEPATIC ENCEPHALOPATHY: A RANDOMIZED CONTROLLED TRIAL.
    Akbar, Muneeba
    Jabeen, Moqadsa
    Nayyer, Faiqua
    Maryam
    Sardar, Usama
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 5 (05): : 3259 - 3262
  • [28] Long-term management of hepatic encephalopathy with lactulose and/or rifaximin: a review of the evidence
    Hudson, Mark
    Schuchmann, Marcus
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 31 (04) : 434 - 450
  • [29] Primary prophylaxis of overt hepatic encephalopathy in patients with cirrhosis: An open labeled randomized controlled trial of lactulose versus no lactulose
    Sharma, Praveen
    Sharma, Barjesh Chander
    Agrawal, Amit
    Sarin, Shiv Kumar
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 (08) : 1329 - 1335
  • [30] Comparison of probiotics and lactulose in the treatment of minimal hepatic encephalopathy in rats
    Lin Jia
    World Journal of Gastroenterology, 2005, (06) : 908 - 911
12345